COGNITION THERAPEUTICS INC (CGTX:NASDAQ)
$0.749 -0.0101 (-1.3305%)
Analysed COGNITION THERAPEUTICS INC (CGTX:NASDAQ) News Sources
Cognition Therapeutics Announces New Composition of Matter Patent, Extending Patent Protection for Lead Candidate, Zervimesine (CT1812) Through 2045
16-06-2026
yahoo.com
Cognition Therapeutics Advances After FDA Supports Key Elements of Pivotal Trial Plan (CGTX)
24-06-2026
advfn.com
Cognition Therapeutics Gets Positive FDA Feedback Over Phase 3 Study Of DLB Psychosis – But CGTX Stock Just Crashed 33%
24-06-2026
stocktwits.com
Cognition Therapeutics Participating in Fireside Chat at B. Riley Securities' Mind, Muscle & Vision Summit
13-07-2026
yahoo.com
Cognition Therapeutics Reports Financial Results for the Second Quarter 2026 and Provides Business Update
06-08-2026
yahoo.com
Cognition Therapeutics, Inc. (CGTX) Reports Q2 Loss, Lags Revenue Estimates
06-08-2026
yahoo.com
Cognition Therapeutics to Present at H.C. Wainwright Global Investment Conference
08-09-2026
yahoo.com
Cognition Therapeutics Announces Issuance of Composition of Matter Patent, Extending Protection for Zervimesine (CT1812) Through 2045
13-10-2026
yahoo.com
Cognition Therapeutics Secures US Patent for Zervimesine Through 2045 Ahead of Planned Phase 3 Development
13-10-2026
advfn.com
Cognition Therapeutics Announces Alignment with FDA on Pivotal Phase 3 Trial of Zervimesine (CT1812) in Dementia with Lewy Bodies
22-10-2026
yahoo.com
What is the current price of COGNITION THERAPEUTICS INC (CGTX:NASDAQ)?
The current price of COGNITION THERAPEUTICS INC (CGTX:NASDAQ) is $0.749.
COGNITION THERAPEUTICS INC (CGTX:NASDAQ) absolute price change since previous trading day?
The absolute price change of COGNITION THERAPEUTICS INC (CGTX:NASDAQ) since the previous trading day is $-0.0101.
COGNITION THERAPEUTICS INC (CGTX:NASDAQ) percentage price change since previous trading day?
The percentage price change of COGNITION THERAPEUTICS INC (CGTX:NASDAQ) since the previous trading day is -1.3305%.
What is the most recent average sentiment score for COGNITION THERAPEUTICS INC (CGTX:NASDAQ)?
The most recent average sentiment score for COGNITION THERAPEUTICS INC (CGTX:NASDAQ) is 69 out of 100.
What is the most recent average sentiment for COGNITION THERAPEUTICS INC (CGTX:NASDAQ)?
The most recent sentiment for COGNITION THERAPEUTICS INC (CGTX:NASDAQ) is .
SEC-8K** Filing Available For COGNITION THERAPEUTICS INC (CGTX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.